CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis

Published:2023-01 Issue: Volume:66 Page:100913
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Wu Jing,Zhou Zhijun,Li Jin,Liu Huifang,Zhang Huaqi,Zhang Junchang,Huang Weibin,He Yulong,Zhu Shiyu,Huo Mingyu,Liu Mingyang,Zhang Changhua

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference48 articles.

1. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

2. Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma;Bohm;J. Clin. Investig.,2016

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

4. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer;Chang;Int. J. Biol. Sci.,2021

5. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage;Chou;Proc. Natl. Acad. Sci. USA,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation;Drug Resistance Updates;2024-11

2. CYP1B1 Promotes PARPi-Resistance via Histone H1.4 Interaction and Increased Chromatin Accessibility in Ovarian Cancer;Drug Resistance Updates;2024-09

3. Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives;MedComm;2024-08-24

4. CHD4 R975H mutant activates tumorigenic pathways and promotes stemness and M2-like macrophage polarization in endometrial cancer;Scientific Reports;2024-08-10

5. OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway;Molecular Cancer;2024-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3